RCM
RA Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-564,102
| Closed | -$7.96M | – | 88 |
|
|
2020
Q4 | $7.96M | Sell |
564,102
-1,764,596
| -76% | -$24.9M | 0.11% | 74 |
|
|
2020
Q3 | $36.5M | Hold |
2,328,698
| – | – | 0.67% | 39 |
|
|
2020
Q2 | $40.8M | Buy |
2,328,698
+367,489
| +19% | +$6.44M | 0.8% | 32 |
|
|
2020
Q1 | $28.8M | Buy |
1,961,209
+86,000
| +5% | +$1.26M | 0.91% | 30 |
|
|
2019
Q4 | $47M | Hold |
1,875,209
| – | – | 1.43% | 19 |
|
|
2019
Q3 | $28.2M | Hold |
1,875,209
| – | – | 1.68% | 17 |
|
|
2019
Q2 | $46.9M | Hold |
1,875,209
| – | – | 2.52% | 10 |
|
|
2019
Q1 | $42.7M | Hold |
1,875,209
| – | – | 1.84% | 15 |
|
|
2018
Q4 | $56.2M | Buy |
1,875,209
+174,192
| +10% | +$5.22M | 3.27% | 11 |
|
|
2018
Q3 | $48.7M | Buy |
+1,701,017
| New | +$48.7M | 2.61% | 15 |
|